Christopher G. Clement
Plus aucun poste en cours
Profil
Mr. Christopher G.
Clement is President, Chief Executive Officer & Director at DARA BioSciences, Inc. He is on the Board of Directors at DARA BioSciences, Inc.
Mr. Clement was previously employed as President & Chief Executive Officer by Savient Pharmaceuticals, Inc., Chairman & Chief Executive Officer by Epicyte Pharmaceutical, Inc., Vorstand Marketing & Vizepräsident by Ares-Serono Group, and Vice President & GM-Global Franchises by G.D.
Searle & Co., Inc. He also served on the board at Neos Therapeutics, Inc.
He received his undergraduate degree from Mercy College.
Anciens postes connus de Christopher G. Clement
| Sociétés | Poste | Fin |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Directeur Général | 18/11/2008 |
Epicyte Pharmaceutical, Inc.
 Epicyte Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Epicyte Pharmaceutical, Inc. develops biopharmaceuticals. The American company was founded by Mich B. Hein. Epicyte Pharmaceutical was acquired by Biolex Therapeutics, Inc. on May 06, 2004. | Président | 01/05/2002 |
Ares-Serono Group
 Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Sales & Marketing | - |
| DARA BIOSCIENCES INC | Directeur Général | - |
| NEOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Christopher G. Clement
| Mercy College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Epicyte Pharmaceutical, Inc.
Epicyte Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Epicyte Pharmaceutical, Inc. develops biopharmaceuticals. The American company was founded by Mich B. Hein. Epicyte Pharmaceutical was acquired by Biolex Therapeutics, Inc. on May 06, 2004. | Health Technology |
Ares-Serono Group
Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
DARA BioSciences, Inc.
 DARA BioSciences, Inc. Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. is a pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. The company's product portfolio includes Soltamox, Gelclair, Bionect and KRN5500. Soltamox offers a choice to patients who prefer or need a liquid form of tamoxifen. Gelclair is an alcohol-free bioadherent oral rinse gel for rapid and effective relief of pain associated with oral mucositis caused by chemotherapy and radiation treatment. The company markets Bionect, a topical treatment for skin irritation and burns associated with radiation therapy, in U.S. oncology/radiology markets. DARA BioSciences was founded by Steven Gorlin on June 22, 2002 and is headquartered in Raleigh, NC. | Health Technology |
